MIR6813

Across TCGA pan-cancer cohorts, MIR6813 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated MIR6813 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher MIR6813 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6813 expression acts as an unfavorable survival marker, although some lineages such as BLCA and GBM show a favorable association.

CESC, UVM, and LGG are the cancer types where MIR6813 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Tertile	III,IV	0.352	0.769	<.001	70	view →
UVM	OS	Tertile	III,IV	0.241	0.765	.002	66	view →
LGG	DFS	Median	All	0.324	0.468	<.001	49	view →
LIHC	OS	Tertile	All	0.458	0.726	<.001	39	view →
DLBC	DFS	Median	All	0.642	0.982	.001	32	view →
LAML	DFS	Tertile	All	0.210	0.554	.004	24	view →
SKCM	DFS	Median	II,III,IV	0.150	0.270	.009	20	view →
BLCA	DFS	Tertile	All	0.680	0.583	.017	20	view →
COAD	OS	Tertile	All	0.416	0.721	.039	18	view →
ESCA	DFS	Tertile	II,III,IV	0.376	0.558	.011	15	view →
STAD	DFS	Quartile	III,IV	0.312	0.530	.005	12	view →
KIRC	DFS	Tertile	III,IV	0.649	0.782	.038	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

MIR6813–CESC (DFS)

Open the CESC breakdown →